05/30/2024
5:00 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
7:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
4:42 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
4:53 PM | Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Jerman Michael Allen (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
6:00 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
12/27/2023
4:27 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/27/2023
4:33 PM | Bay Shore Trust (Reporting)
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:50 PM | MIRA Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/01/2023
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
3:15 PM | Jerman Michael Allen (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2023
3:18 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
11/20/2023
7:10 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:31 PM | Daly Brian Frederick (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2023
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
3:23 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/12/2023
3:26 PM | McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2023
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 424B3 | |
09/15/2023
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/31/2023
4:27 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
4:38 PM | Bay Shore Trust (Reporting)
Cappy George (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | Chapman Christopher C JR (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
5:00 PM | MIRA Pharmaceuticals (Issuer)
Nicholoudis Christos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:25 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D | |
08/04/2023
12:42 PM | Bay Shore Trust (Reporting)
Cappy George (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
11:59 AM | MIRA Pharmaceuticals (Filer)
| Form 424B1 | |
08/04/2023
12:01 PM | MIRA Pharmaceuticals (Filer)
| Form 424B4 | |
08/02/2023
11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
08/02/2023
4:58 PM | Kroenig Bradley (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:00 PM | McColl Hugh III (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
08/02/2023
5:03 PM | MIRA Pharmaceuticals (Issuer)
Nicholoudis Christos (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:05 PM | MIRA Pharmaceuticals (Issuer)
Tuck Talhia (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:08 PM | MIRA Pharmaceuticals (Issuer)
Vorhoff David C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:10 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:13 PM | Bay Shore Trust (Reporting)
Cappy George (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
4:49 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
4:52 PM | Chapman Christopher C JR (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
4:55 PM | Kaplin Adam (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2023
4:24 PM | MIRA Pharmaceuticals (Filer)
| Form CERT | |
07/31/2023
2:54 PM | MIRA Pharmaceuticals (Filer)
| Form 8-A12B | |
07/28/2023
2:14 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/21/2023
4:20 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/18/2023
4:14 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
07/14/2023
4:08 PM | MIRA Pharmaceuticals (Filer)
| Form S-1/A | |
06/29/2023
3:39 PM | MIRA Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
